Diseases [C] » Immune System Diseases [C20] » Immunoproliferative Disorders » Lymphoproliferative Disorders » Leukemia, Lymphoid
Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Leukemia » Leukemia, Lymphoid
Diseases [C] » Hemic and Lymphatic Diseases [C15] » Lymphatic Diseases » Lymphoproliferative Disorders » Leukemia, Lymphoid
Description
Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. MeSH
Hierarchy View
Subtype Terms (5)
Leukemia, B-Cell
88 drugs (41 approved, 47 experimental)
Leukemia, Biphenotypic, Acute
59 drugs (39 approved, 20 experimental)
Leukemia, Prolymphocytic
69 drugs (46 approved, 23 experimental)
Leukemia, T-Cell
31 drugs (23 approved, 8 experimental)
Precursor Cell Lymphoblastic Leukemia-Lymphoma
325 drugs (154 approved, 171 experimental)
Approved Indicated Drugs (2)
Phase 4 Indicated Drugs (19)
Phase 3 Indicated Drugs (13)
Phase 2 Indicated Drugs (41)
Phase 1 Indicated Drugs (30)
Other Experimental Indicated Drugs (10)
Organization Involved with Phase 4 Indications (63)
Associazione Italiana Ematologia Oncologia Pediatrica
Badalona Hospital Germans Trias i Pujol
Canadian Immunization Research Network
Chinese Academy of Medical Sciences
Danish Child Cancer Foundation
East Valley Hematology and Oncology Medical Group
German Federal Ministry of Education and Research
Huazhong University of Science and Technology
Huizhou People's Central Hospital
National Cancer Institute (NCI)
National University of Singapore
Nordic Society for Pediatric Hematology and Oncology
Programa Nacional de Cancer Infantil de Chile
Organization Involved with Phase 3 Indications (180)
Aamu Pediatric Cancer Foundation
Acreditar - Associação de Pais e Amigos das Crianças com Cancro
Albert Einstein Israelite Hospital
Arbeitsgemeinschaft medikamentoese Tumortherapie
Azienda Ospedaliera San Gerardo di Monza
Bangabandhu Sheikh Mujib Medical University
Beijing InnoCare Pharma Tech Co., Ltd.
Blood and Marrow Transplant Clinical Trials Network
Cancer and Leukemia Group B (CALGB)
Center for International Blood and Marrow Transplant Research
Changzhou Jinyuan Pharmaceutical Manufacturing Co., Ltd.
Children's Cancer and Leukaemia Group
Cook Children's Medical Center
Dutch Childhood Oncology Group
Eastern Cooperative Oncology Group
ECOG-ACRIN Cancer Research Group
Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany
Grupo Español de Leucemia Linfocítica Crónica (GELLC)
Grupo Português De Leucemias Pediátricas
Gruppo Italiano Malattie EMatologiche dell'Adulto
Hoosier Cancer Research Network
Hospital Civil Juan I. Menchaca
HOVON - Dutch Haemato-Oncology Association
Icahn School of Medicine at Mount Sinai
Instituto de Investigacion de Cancer de la Infancia y la Adolescencia
Instituto de Investigacion en Cancer de la Infancia y la Adolescencia
Japan Adult Leukemia Study Group
Katholieke Universiteit Leuven
Maine Children's Cancer Program
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of General Medical Sciences (NIGMS)
National Institutes of Health (NIH)
National University of Malaysia
Nordic CLL Study Group (NCLLSG)
Oregon Health and Science University
People's Liberation Army of China
Royal Marsden Hospital NHS Trust
San Jorge Children's Hospital, Puerto Rico
Shandong Lanjin Pharmaceuticals Co.,Ltd
Shijiazhuang Pharma Group (CSPC)
Swiss Group for Clinical Cancer Research
The Swedish Childhood Cancer Foundation
The University of Texas, Dallas
Universitaetsklinikum Schleswig-Holstein
University of California, Irvine
University of California, Los Angeles
University of Rome Tor Vergata
University of Texas at Houston
University of Western Australia
Vall d'Hebron Institute of Research, Galatea Clinic
Organization Involved with Phase 2 Indications (326)
Academic and Community Cancer Research United
Assistance Publique - Hôpitaux de Paris
Azienda Ospedaliera Antonio Cardarelli
Azienda Ospedaliera Ospedale Civile di Legnano
Azienda Osperdaliera Vincenzo Cervello Divisione
Bambino Gesù Hospital and Research Institute
Betta Pharmaceuticals Co.,Ltd.
Cancer Biotherapy Research Group
Case Western Reserve University
Children's National Medical Center
Chinese University of Hong Kong
Chongqing Precision Biotech Co., Ltd
Chronic Lymphocytic Leukemia Research Consortium
City of Hope National Medical Center
Complessa di Ematologia and Dir Departmento
Cyclacel Pharmaceuticals, Inc.
CZECRIN - Czech Clinical Research Infrastructure Network
Department of Health, United Kingdom
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Federal University of Rio de Janeiro
Federal University of Rio Grande do Sul
First People's Hospital of Foshan
Fondazione Matilde Tettamanti Menotti De Marchi Onlus
Fundacao Hospital Amaral Carvalho
Gottfried Wilhelm Leibniz Universität Hannover
Grupo Cooperativo de Hemopatías Malignas
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Grupo Espanol de trasplantes hematopoyeticos y terapia celular
Guangdong Pharmaceutical University
Hackensack University Medical Center
Henan University of Traditional Chinese Medicine
Herbert Irving Comprehensive Cancer Center
Hoag Memorial Hospital Presbyterian
HOANNJ-Carol G. Simon Cancer Center
Hospital de Clinicias da UICAMP
Hospital Infantil Universitario Niño Jesús, Madrid, Spain
Hospital Nossa Senhora da Conceicao
Hospital Santa Marcelina, Sao Paulo, Brasil
Infinity Pharmaceuticals, Inc.
Innovative Therapies For Children with Cancer Consortium
Institut de Cancérologie de la Loire (ICLN)
Institut de Cancerologie de l'Ouest Paul Papin
Institute of Hematology and Blood Transfusion, Czech Republic
Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti
Instituto Mexicano del Seguro Social
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Istituti Ospitalieri di Cremona
Istituto Nazionale per lo Studio e la Cura dei Tumori
Istitutp di Ematologia ed Oncologia Medica
James Graham Brown Cancer Center
JP Moulton Charitable Foundation
Korea Research Institute of Bioscience and Biotechnology
La Jolla Pharmaceutical Company
Medical University of South Carolina
Memorial Sloan-Kettering Cancer Center
Methodist Cancer Center, Houston, Texas
National Comprehensive Cancer Network
National Hospital Organisation Nagoya Medical Centre
National Institute on Aging (NIA)
North Central Cancer Treatment Group
Ospedale S. Giovanni Bellinzona
Pavlov First Saint Petersburg State Medical University
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Presidio Ospedaliero Spedali Civili di Brescia
Rio de Janeiro Federal University
Santobono - Pausilipon Hospital
Service Clinique des Maladies du Sang
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Shanghai Zhangjiang Biotechnology Limited Company
Shenzhen Institute for Innovation and Translational Medicine
Simcere Pharmaceutical Co., Ltd
State University of New York, Buffalo
Teaching Hospital Královské Vinohrady (FNKV)
Technical University of Dresden
Technical University of Munich
The Foundation Institute San Raffaele G. Giglio of Cefalù
The Lymphoma Academic Research Organisation
The Royal Bournemouth Hospital
The Scientific and Technological Research Council of Turkey
The Wayne D. Kuni and Joan E. Kuni Foundation
Universidad Autonoma de Madrid
Universidade Federal do Parana
Universita Degli Studi La Sapeinza
Université catholique de Louvain
University Hospital Hradec Kralove
University of Alabama, Birmingham
University of British Columbia
University of California, Davis
University of California, San Diego
University of California, San Francisco
University of Colorado, Denver
University of Medicine and Dentistry of New Jersey
University of Roma La Sapienza
University of Southern California
U.O. di Ematologia- Ospedale dell'Angelo - Mestre
Virginia Commonwealth University
Vita-Salute University of Milano. Italy
Organization Involved with Phase 1 Indications (102)
Acetylon Pharmaceuticals Incorporated
Alex's Lemonade Stand Foundation
Applied Physiology Research Center
Beijing Sanwater Biological Technology Co., Ltd.
Boryung Pharmaceutical Company
Cellular Biomedicine Group Ltd.
Chao Family Comprehensive Cancer Center
Damon Runyon Cancer Research Foundation
Hebei Senlang Biotechnology Inc., Ltd.
Laboratoire français de Fractionnement et de Biotechnologies
MingSight Pharmaceuticals Pty Limited
Nanjing Bioheng Biotech Co., Ltd.
Seyyed-alshohada hospital of Isfahan
Shanghai Longyao Biotechnology Inc., Ltd.
South Plains Oncology Consortium
Organization Involved with Other Experimental Indications (15)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
